CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
6125 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C05601 | BRD-K83776863 | tryptophan | CASR|IDO1|SLC36A1|WARS|WARS2 | serotonin receptor partial agonist | Details | |
| C05602 | BRD-K49685476 | TTNPB | RARA|RARB|RARG | retinoid receptor agonist | Details | |
| C05603 | BRD-K64852730 | TTP-22 | CSNK2A1 | casein kinase inhibitor | Details | |
| C05604 | BRD-K44590731 | TU-2100 | Details | |||
| C05605 | BRD-A19958636 | tuaminoheptane | Details | |||
| C05606 | BRD-K00627859 | tubastatin-a | HDAC6 | HDAC inhibitor | Details | |
| C05607 | BRD-K99621550 | tubocurarine | ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN | acetylcholine receptor antagonist | Details | |
| C05608 | BRD-K26026438 | tucatinib | ERBB2 | EGFR inhibitor | Details | |
| C05609 | BRD-K56086081 | TUG-770 | FFAR1 | free fatty acid receptor agonist | Details | |
| C05610 | BRD-K24282351 | TUG-891 | FFAR4 | free fatty acid receptor agonist | Details | |
| C05611 | BRD-A37441042 | tulobuterol | ADRB2 | adrenergic receptor agonist | Details | |
| C05612 | BRD-K28360340 | TW-37 | BCL2|BCL2L1|MCL1 | BCL inhibitor | Details | |
| C05613 | BRD-K94176593 | TWS-119 | GSK3B|JUN|MYC | glycogen synthase kinase inhibitor | Details | |
| C05614 | BRD-K36040345 | TXA127 | angiotensin receptor agonist | Details | ||
| C05615 | BRD-K66584608 | TY-52156 | S1PR3 | sphingosine 1-phosphate receptor antagonist | Details | |
| C05616 | BRD-K37753391 | tylosin | protein synthesis inhibitor | Details | ||
| C05617 | BRD-M08959712 | tyloxapol | LPL|NFKB2 | NFkB pathway inhibitor | Details | |
| C05618 | BRD-K64414150 | tymazoline | Details | |||
| C05619 | BRD-K76064317 | tyrphostin-AG-1296 | FLT3 | FLT3 inhibitor | Details | |
| C05620 | BRD-K68336408 | tyrphostin-AG-1478 | EGFR|MAPK14 | EGFR inhibitor | Details | |
| C05621 | BRD-K49657628 | tyrphostin-AG-18 | EGFR | EGFR inhibitor; tyrosine kinase inhibitor | Details | |
| C05622 | BRD-K34533029 | tyrphostin-AG-494 | EGFR | EGFR inhibitor | Details | |
| C05623 | BRD-K87919739 | tyrphostin-AG-825 | ERBB2 | protein tyrosine kinase inhibitor | Details | |
| C05624 | BRD-K17415526 | tyrphostin-AG-835 | EGFR | protein tyrosine kinase inhibitor | Details | |
| C05625 | BRD-K59469039 | tyrphostin-AG-879 | ERBB2|KDR|NTRK1 | tyrosine kinase inhibitor | Details | |
| C05626 | BRD-K60184833 | tyrphostin-AG-99 | EGFR | tyrosine kinase inhibitor | Details | |
| C05627 | BRD-K40255344 | tyrphostin-A9 | protein tyrosine kinase inhibitor; tyrosine kinase inhibitor | Details | ||
| C05628 | BRD-K63169195 | U-0124 | MEK inhibitor | Details | ||
| C05629 | BRD-K91701654 | U-0126 | AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1 | MEK inhibitor | Details | |
| C05630 | BRD-K08953028 | U-0521 | COMT | catechol O methyltransferase inhibitor | Details | |
| C05631 | BRD-K77867004 | U-104 | CA1|CA12|CA2|CA9 | carbonic anhydrase inhibitor | Details | |
| C05632 | BRD-K22025381 | U-18666A | oxidosqualene cyclase inhibitor | Details | ||
| C05633 | BRD-K53532120 | U-50488-(-) | OPRK1 | opioid receptor agonist | Details | |
| C05634 | BRD-K20995441 | U-54494A | OPRK1 | opioid receptor agonist | Details | |
| C05635 | BRD-K77070363 | U-75799E | GHSR | growth hormone releasing factor agonist | Details | |
| C05636 | BRD-K70281171 | U-99194 | DRD3 | dopamine receptor antagonist | Details | |
| C05637 | BRD-K38966689 | UAMC-00039 | DPP4|DPP7 | dipeptidyl peptidase inhibitor | Details | |
| C05638 | BRD-A14574269 | UB-165 | CHRNA3|CHRNA4|CHRNB2 | acetylcholine receptor agonist | Details | |
| C05639 | BRD-K59574735 | ubenimex | LTA4H|RNPEP | leukotriene synthesis inhibitor | Details | |
| C05640 | BRD-A45499626 | UBP-296 | GRIK1 | glutamate receptor antagonist | Details | |
| C05641 | BRD-K79753741 | UBP-302 | GRIK1 | glutamate receptor antagonist | Details | |
| C05642 | BRD-K09597601 | UBP-310 | GRIK1|GRIK5 | glutamate receptor antagonist | Details | |
| C05643 | BRD-K73610817 | UC-112 | XIAP | XIAP inhibitor | Details | |
| C05644 | BRD-K50325075 | UCL-2077 | slow afterhyperpolarization channel blocker | Details | ||
| C05645 | BRD-K20480395 | UF-010 | HDAC1|HDAC2|HDAC3|HDAC8 | HDAC inhibitor | Details | |
| C05646 | BRD-K84173274 | ufenamate | PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
| C05647 | BRD-K66715657 | UH-232-(+) | DRD2|DRD3|DRD4|HTR1A | dopamine receptor antagonist | Details | |
| C05648 | BRD-K57011718 | UK-356618 | MMP13|MMP14|MMP2|MMP3|MMP9 | metalloproteinase inhibitor | Details | |
| C05649 | BRD-K06294530 | UK-383367 | BMP1 | Procollagen C-Endopeptidase Inhibitors | Details | |
| C05650 | BRD-K19558579 | UK-5099 | SLC16A1 | monocarboxylate transporter inhibitor | Details | |
| C05651 | BRD-A61633223 | ulifloxacin | Details | |||
| C05652 | BRD-K64381438 | ulipristal | PGR | progesterone receptor antagonist | Details | |
| C05653 | BRD-K46692793 | umeclidinium | CHRM1|CHRM2|CHRM3 | acetylcholine receptor antagonist | Details | |
| C05654 | BRD-K30933884 | UNBS-5162 | CC chemokine receptor antagonist | Details | ||
| C05655 | BRD-K60635008 | UNC-2327 | PRMT3 | protein arginine N-methyltransferase inhibitor | Details | |
| C05656 | BRD-K46344388 | UNC-3230 | PIP5K1C | phosphatidyl-inositol activator | Details | |
| C05657 | BRD-K22229656 | UNC-926 | L3MBTL1 | MBT inhibitor | Details | |
| C05658 | BRD-K77428767 | UNC0224 | EHMT1|EHMT2 | histone lysine methyltransferase inhibitor | Details | |
| C05659 | BRD-K74236984 | UNC0321 | EHMT2 | histone lysine methyltransferase inhibitor | Details | |
| C05660 | BRD-K13060017 | UNC0631 | EHMT2 | histone lysine methyltransferase inhibitor | Details | |
| C05661 | BRD-K86856088 | UNC0638 | EHMT1|EHMT2 | histone lysine methyltransferase inhibitor | Details | |
| C05662 | BRD-K60130390 | UNC0642 | EHMT1|EHMT2 | histone lysine methyltransferase inhibitor | Details | |
| C05663 | BRD-K87465484 | UNC0646 | EHMT2 | histone lysine methyltransferase inhibitor | Details | |
| C05664 | BRD-K02988401 | UNC0737 | EHMT1|EHMT2 | histone lysine methyltransferase inhibitor | Details | |
| C05665 | BRD-K83189926 | UNC1215 | L3MBTL3 | L3MBTL antagonist | Details | |
| C05666 | BRD-K26989966 | UNC1999 | EZH2 | histone lysine methyltransferase inhibitor | Details | |
| C05667 | BRD-K91283740 | UNC2025 | FLT3|MERTK | MER tyrosine kinase inhibitor; FLT3 inhibitor | Details | |
| C05668 | BRD-K01773560 | UNC2250 | MERTK | MER tyrosine kinase inhibitor | Details | |
| C05669 | BRD-K21906513 | UNC669 | L3MBTL1 | L3MBTL antagonist | Details | |
| C05670 | BRD-K19189338 | undecylenic-acid | other antifungal | Details | ||
| C05671 | BRD-K77950083 | UPF-1069 | PARP2 | PARP inhibitor | Details | |
| C05672 | BRD-K38332599 | uprosertib | AKT1|AKT2|AKT3 | AKT inhibitor | Details | |
| C05673 | BRD-K80129304 | uracil | DPYD|UCKL1 | Details | ||
| C05674 | BRD-K10180294 | uracil-mustard | DNA synthesis inhibitor | Details | ||
| C05675 | BRD-K73196317 | urapidil | HTR1A | adrenergic receptor antagonist | Details | |
| C05676 | BRD-K92169341 | URB597 | FAAH|FAAH2|TRPA1 | FAAH inhibitor | Details | |
| C05677 | BRD-K88052444 | urea | ARG1|CA2|CTNNB1 | hydroxy radical formation stimulant | Details | |
| C05678 | BRD-K24297741 | urethane | local anesthetic | Details | ||
| C05679 | BRD-K01295354 | uric-acid | PYGL | Details | ||
| C05680 | BRD-K13050303 | uridine | LSM6|TYMP | dopamine receptor agonist | Details | |
| C05681 | BRD-K18323388 | uridine-triacetate | Details | |||
| C05682 | BRD-A89637065 | uridine-5'-triphosphate | P2RY11|P2RY2|P2RY4|P2RY6|UCK2 | purinergic receptor activator | Details | |
| C05683 | BRD-K66908976 | URMC-099 | CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2 | mixed lineage kinase inhibitor | Details | |
| C05684 | BRD-K45245728 | ursodeoxycholyltaurine | cholesterol inhibitor | Details | ||
| C05685 | BRD-K15697815 | ursodiol | NR1H4 | nuclear factor erythroid derived; like (NRF2) activator | Details | |
| C05686 | BRD-K68185022 | ursolic-acid | HSD11B1|PLA2G1B|PTPN1|PYGM | ATPase inhibitor; NFkB pathway inhibitor; STAT inhibitor | Details | |
| C05687 | BRD-A12417644 | usniacin-(+) | PTPN1 | MAP kinase activator | Details | |
| C05688 | BRD-K75052463 | V-51 | adrenergic receptor antagonist | Details | ||
| C05689 | BRD-K59424860 | val | BCAT1|PCCB|VARS | Details | ||
| C05690 | BRD-K46435977 | valaciclovir | DNA polymerase inhibitor | Details | ||
| C05691 | BRD-K12994359 | valdecoxib | CA12|PTGS2 | cyclooxygenase inhibitor | Details | |
| C05692 | BRD-A56613951 | valethamate | CHRM1|CHRM4|CHRM5 | acetylcholine receptor antagonist | Details | |
| C05693 | BRD-A50922295 | valganciclovir | DNA synthesis inhibitor | Details | ||
| C05694 | BRD-K33813875 | valnemulin | bacterial 50S ribosomal subunit inhibitor | Details | ||
| C05695 | BRD-A96644976 | valnoctamide | arachidonic acid acylation inhibitor; benzodiazepine receptor agonist | Details | ||
| C05696 | BRD-K41260949 | valproic-acid | ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A | HDAC inhibitor | Details | |
| C05697 | BRD-K54698528 | valpromide | epoxide hydolase inhibitor | Details | ||
| C05698 | BRD-K32804101 | valrocemide | Details | |||
| C05699 | BRD-K72951360 | valrubicin | TOP2A | DNA inhibitor; topoisomerase inhibitor | Details | |
| C05700 | BRD-K45158365 | valsartan | AGTR1 | angiotensin receptor antagonist | Details |